
Pasirinkite etiketę
rodoma tiesiai ant flakonoP21
Cognition
- Siunčiame iš Vokietijos
Užsakymas
- DHL su sekimu
- Diskreti pakuotė
Trumpai
P21 skaičiais
Pagrindiniai rodikliai iš mūsų žinyno.
Visas žinyno įrašas- Class
- CNTF mimetic / BDNF enhancer
- Half-life
- shorthence 2 doses per week
- Use
- Subcutaneous2x per week
- Sizes
- 10 mg1 size in the shop
What studies show
All 3 sources in the lexicon- Kazim et al., Neurobiology of Disease, 2014
- Khatoon et al., Journal of Alzheimer's Disease, 2015
- Bolognin et al., Neurobiology of Aging, 2014
Produktui P21 laboratorinės analizės dar nėra. Balsuoti už taiUžsakykite tyrimą, mes apmokame pusęVisos laboratorinės analizės
Žinios
Viskas apie P21
Išsami informacija netrukus.
Pravers
Ko dar jums reikės
Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.
Insulino švirkštai
10 vnt. · 5.50 €
Spiritinės servetėlės
50 vnt. · 10 €
Kiek vandens?
Vienetai ant švirkšto jūsų flakono dydžiui.
Atidaryti skaičiuoklę →Is P21 approved or studied in humans?
No. There is no approval and as of 26 October 2026 ClinicalTrials.gov lists no trial with P021. According to a conflict of interest statement from 2024 a company of the developer intends to develop P021 as a medicine. So far all data come from cells and animals.
What is P21 made of?
Of a tetrapeptide from the most active region of CNTF, plus a glycine with an adamantane group at the end. The formula is Ac-DGGL(A)G-NH2. The adamantane is meant to ease the way into the brain and slow breakdown by enzymes. The first paper from 2010 called the peptide P21, later ones P021.
What did the Alzheimer models show?
Mice with three Alzheimer genes received P021 for twelve months from an age of 9 to 10 months. Abnormal tau declined clearly, soluble amyloid fell, memory and the formation of new nerve cells improved. When dosing started at 3 months, tau and amyloid changes largely did not appear and fewer animals died. Even dosing only before and shortly after birth later reduced tau changes and amyloid plaques.
What did old rats show?
Rats aged 22 to 24 months lost less learning and memory performance with P021 and made more BDNF and more new nerve cells. A second paper showed that P021 reaches the brain and lowered the tau level in the cerebrospinal fluid to that of young rats, but not amyloid.
Are there findings outside Alzheimer's?
Yes, mixed ones. In a mouse model of Down syndrome dosing before and shortly after birth prevented developmental delay and later memory problems. In a model of CDKL5 disorder P021 helped in cell culture, but in mice BDNF did not rise and the benefit stayed small.
How was P021 given in the studies?
In the animal studies mostly with the food, so by mouth, often over many months. The lexicon entry instead describes dosing under the skin. There are no human data on that.
Which side effects are known?
There are no solid data because P021 has never been tested in humans. In old rats it caused no detectable immune reaction. That cannot be transferred to humans.
Susiję
Susiję produktai
Selank
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
Dydžių: 3
Patikrinta laboratorijoje
= nuo 10 €/flakonas
Selank Nasal
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
1 dydis
Semax
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
Dydžių: 3
Patikrinta laboratorijoje
= nuo 10 €/flakonas
Semax Nasal
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
1 dydis
P21